EUVIMEDEUVIMED entdecken
Crossref

Trends in the Perioperative Practices for Immunological Assessment and Immunosuppression Strategies for Patients Undergoing Intestinal Transplantation at American Transplant Centers

Mohammed Abusuliman, Syed-Mohammed Jafri, Bryant B Summers, Thiago Beduschi, Justin Boike, Douglas G Farmer, Simon Horslen, Kishore Lyer, Alan N Langnas, Richard S Mangus, Cal S Matsumoto, Alisha M Mavis und 8 weitere

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.01.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Mohammed Abusuliman und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan. Electronic address: Dr.salah.ma@gmail.com. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Intestines, Graft Rejection, Organ Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intestinal transplantation (IT) is a complex procedure that requires nuanced immunosuppressive strategies to optimize patient outcomes. Despite advancements, significant variability remains in immunosuppressive protocols across transplant centers due to a lack of consensus on the optimal approaches for induction, maintenance, and clinical testing. This variability complicates standardization and identification of best practices for IT recipients. METHODS: A descriptive survey study was conducted to characterize immunosuppressive and testing strategies in IT at major transplant centers in the United States. Ten centers known to have performed over 10 ITs since 2015 were selected from the Scientific Registry of Transplant Recipients database. A 22-question survey was distributed to surgical directors, collecting data on pre-, peri-, and post-transplant immunological testing, desensitization strategies, immunosuppressive regimens, and management of antibody-mediated rejection (AMR) and acute cellular rejection (ACR). RESULTS: Nine centers (90%) responded. All centers conducted pretransplant human leukocyte antigen (HLA) and donor-specific antibody (DSA) testing, with varying frequencies and methodologies. Desensitization was reported by 44% of centers for isolated IT and by 22% for multivisceral transplants. Induction therapy predominantly involved antithymocyte globulin (89%) and rituximab (44%). Tacrolimus was universally used for maintenance, with varying trough level targets across centers. Post-transplant DSA testing was performed by all centers, and protocol-driven endoscopic bowel biopsies were routine at 67% of centers. AMR was diagnosed at 89% of centers, with plasmapheresis and IVIG being the most common treatments. Variability was noted in desensitization practices and AMR management. CONCLUSION: This survey highlights considerable consistency in pre- and post-transplant testing and immunosuppressive regimens for IT recipients, while significant variability exists in desensitization strategies and AMR management. Further research is needed to standardize these practices to improve patient outcomes across transplant centers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunosuppressive AgentsIntestinesGraft RejectionOrgan TransplantationImmunosuppression TherapyPractice Patterns, Physicians'Perioperative CareHumansUnited StatesHLA AntigensHistocompatibility Testing

Substanzen

Immunosuppressive AgentsHLA Antigens

Autor:innen und Institutionen

  • Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan. Electronic address: Dr.salah.ma@gmail.com.
  • Department of Gastroenterology, Henry Ford Hospital, Detroit, Michigan.
  • Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Department of Surgery, University of Florida College of Medicine, Gainesville, Florida.
  • Department of Gastroenterology and Hepatology, Northwestern Feinberg School of Medicine, Chicago, Illinois.
  • Department of Surgery, University of California Los Angeles Health, Los Angeles, California.

Zitieren

APA

Abusuliman, M., Jafri, S. M., Summers, B. B., Beduschi, T., Boike, J., Farmer, D. G., Horslen, S., Lyer, K., Langnas, A. N., Mangus, R. S., Matsumoto, C. S., Mavis, A. M., Mazariegos, G. V., Nagai, S., O'Leary, J., Schiano, T. D., Sudan, D. L., Abusuliman, A., Sulejmani, N., & Segovia, M. C. (2025). Trends in the Perioperative Practices for Immunological Assessment and Immunosuppression Strategies for Patients Undergoing Intestinal Transplantation at American Transplant Centers. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.01.002

Vancouver

Abusuliman M, Jafri SM, Summers BB, Beduschi T, Boike J, Farmer DG, et al. Trends in the Perioperative Practices for Immunological Assessment and Immunosuppression Strategies for Patients Undergoing Intestinal Transplantation at American Transplant Centers. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.01.002

BibTeX
@article{Abusuliman2025,
  author = {Abusuliman, Mohammed and Jafri, Syed-Mohammed and Summers, Bryant B and Beduschi, Thiago and Boike, Justin and Farmer, Douglas G and Horslen, Simon and Lyer, Kishore and Langnas, Alan N and Mangus, Richard S and Matsumoto, Cal S and Mavis, Alisha M and Mazariegos, George V and Nagai, Shunji and O'Leary, Jacqueline and Schiano, Thomas D and Sudan, Debra L and Abusuliman, Amr and Sulejmani, Nimisha and Segovia, Maria Cristina},
  title = {Trends in the Perioperative Practices for Immunological Assessment and Immunosuppression Strategies for Patients Undergoing Intestinal Transplantation at American Transplant Centers},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.01.002}
}
Kostenlos starten →